You just read:

Castle Biosciences' Mesothelioma Molecular Test Accurately Stratifies Survival Risk Under Surgical and Non-Surgical Treatment Plans

News provided by

Castle Biosciences Inc.

Apr 29, 2014, 08:00 ET